Publication | Closed Access

The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway

Ginsenoside Rh2Pancreatic CancerCancer ImmunosurveillanceMedicineImmune RegulationTumor ImmunityImmunologyImmune SurveillanceDendritic Cell BiologyImmunotherapyCancer BiologyCell BiologyCancer ResearchDendritic Cells